Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Breast Cancer Stage IV
- Melanoma Stage IV
- Pancreatic Cancer Stage IV
- Prostate Cancer
- Sarcoma
- Squamous Cell Carcinoma
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04628806
- Collaborators
- Klinikum rechts der Isar, TU München, (TUM), Munich, Germany.
- Investigators
- Principal Investigator: Sebastian Zschaeck, MD Charité